OA09637A - Compositions and methods for drug delivery and chromatography - Google Patents
Compositions and methods for drug delivery and chromatographyInfo
- Publication number
- OA09637A OA09637A OA59959A OA59959A OA09637A OA 09637 A OA09637 A OA 09637A OA 59959 A OA59959 A OA 59959A OA 59959 A OA59959 A OA 59959A OA 09637 A OA09637 A OA 09637A
- Authority
- OA
- OAPI
- Prior art keywords
- chromatography
- compositions
- methods
- drug delivery
- drug
- Prior art date
Links
- 238000004587 chromatography analysis Methods 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ016588 | 1988-08-31 | ||
AUPJ018988 | 1988-09-01 | ||
AUPJ061888 | 1988-09-27 | ||
AUPJ105388 | 1988-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA09637A true OA09637A (en) | 1993-04-30 |
Family
ID=27424246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA59959A OA09637A (en) | 1988-08-31 | 1991-02-27 | Compositions and methods for drug delivery and chromatography |
Country Status (1)
Country | Link |
---|---|
OA (1) | OA09637A (en) |
-
1991
- 1991-02-27 OA OA59959A patent/OA09637A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0431080A4 (en) | Compositions and methods for drug delivery and chromatography | |
NZ223630A (en) | Insulin derivative and pharmaceutical compositions | |
EP0274431A3 (en) | Drug delivery compositions and methods | |
GB2222772B (en) | Pharmaceutical compositions | |
GB2219940B (en) | Pharmaceutical compositions | |
EP0491812A4 (en) | Drug delivery compositions | |
EP0403578A4 (en) | Stable pharmaceutical composition | |
GB8825892D0 (en) | Pharmaceutical composition | |
ZA893422B (en) | Pharmaceutical composition | |
EP0443027A4 (en) | Drug composition | |
ZA89552B (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
OA09637A (en) | Compositions and methods for drug delivery and chromatography | |
ZA896624B (en) | Composition and methods for drug delivery and chromatography | |
IL93143A0 (en) | Transdermal drug delivery composition | |
IE892772L (en) | Composition and methods for drug chromatography | |
GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
GB8830406D0 (en) | Pharmaceutical compositions | |
GB8809849D0 (en) | Pharmaceutical composition | |
GB8818118D0 (en) | Pharmaceutical composition | |
GB8827718D0 (en) | Pharmaceutical composition | |
GB8802927D0 (en) | Pharmaceutical composition | |
GB8818098D0 (en) | Pharmaceutical composition | |
GB8802926D0 (en) | Pharmaceutical composition | |
GB8806495D0 (en) | Pharmaceutical composition | |
GB8807384D0 (en) | Pharmaceutical composition |